Positive News SentimentPositive NewsNASDAQ:ACOG Alpha Cognition (ACOG) Stock Price, News & Analysis $9.65 +1.22 (+14.47%) As of 02:33 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Alpha Cognition Stock (NASDAQ:ACOG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alpha Cognition alerts:Sign Up Key Stats Today's Range$8.68▼$9.7950-Day Range$3.75▼$10.5752-Week Range$3.75▼$11.40Volume246,211 shsAverage Volume101,209 shsMarket Capitalization$154.59 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingBuy Company OverviewAlpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.Read More… Alpha Cognition Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreACOG MarketRank™: Alpha Cognition scored higher than 33% of companies evaluated by MarketBeat, and ranked 796th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAlpha Cognition has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlpha Cognition has only been the subject of 2 research reports in the past 90 days.Read more about Alpha Cognition's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Cognition is -3.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Cognition is -3.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Alpha Cognition's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACOG. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Cognition does not currently pay a dividend.Dividend GrowthAlpha Cognition does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACOG. News and Social Media2.7 / 5News SentimentN/A News SentimentAlpha Cognition has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Alpha Cognition this week, compared to 1 article on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alpha Cognition insiders have not sold or bought any company stock.Percentage Held by Insiders14.00% of the stock of Alpha Cognition is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Alpha Cognition's insider trading history. Receive ACOG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Cognition and its competitors with MarketBeat's FREE daily newsletter. Email Address ACOG Stock News HeadlinesAlpha Cognition: Launching A Differentiated Drug Into A Large Alzheimer's Market OpportunityMay 19, 2025 | seekingalpha.comAlpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.May 29, 2025 | American Alternative (Ad)Alpha Cognition, Inc. Announces Participation in the D. ...April 30, 2025 | gurufocus.comACOG Alpha Cognition Inc.April 22, 2025 | seekingalpha.comAlpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John HavensApril 10, 2025 | businesswire.comAlpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John HavensApril 10, 2025 | businesswire.comAlpha Cognition Inc. (ACOG) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comSee More Headlines ACOG Stock Analysis - Frequently Asked Questions How have ACOG shares performed this year? Alpha Cognition's stock was trading at $5.86 at the beginning of the year. Since then, ACOG stock has increased by 60.4% and is now trading at $9.40. View the best growth stocks for 2025 here. How were Alpha Cognition's earnings last quarter? Alpha Cognition, Inc. (NASDAQ:ACOG) posted its earnings results on Thursday, May, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.38. The firm earned $2.93 million during the quarter, compared to analysts' expectations of $0.50 million. Read the conference call transcript. When did Alpha Cognition IPO? Alpha Cognition (ACOG) raised $50 million in an initial public offering on Tuesday, November 12th 2024. The company issued 8,695,653 shares at a price of $5.75 per share. When did the company's lock-up period expire? Alpha Cognition's lock-up period expired on Monday, May 12th. Alpha Cognition had issued 8,695,653 shares in its public offering on November 12th. The total size of the offering was $50,000,005 based on an initial share price of $5.75. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted. Who are Alpha Cognition's major shareholders? Alpha Cognition's top institutional shareholders include AWM Investment Company Inc. (6.84%), Alyeska Investment Group L.P. (2.11%), Altium Capital Management LLC (1.11%) and Corsair Capital Management L.P. (0.88%). How do I buy shares of Alpha Cognition? Shares of ACOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2025Today5/29/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ACOG CIK1655923 WebN/A Phone(858) 344-4375FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$20.00 High Stock Price Target$20.00 Low Stock Price Target$20.00 Potential Upside/Downside+137.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$13.77 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-344.17% Debt Debt-to-Equity RatioN/A Current Ratio1.50 Quick Ratio1.50 Sales & Book Value Annual Sales$2.93 million Price / Sales46.11 Cash FlowN/A Price / Cash FlowN/A Book Value($1.08) per share Price / Book-7.81Miscellaneous Outstanding Shares16,020,000Free Float10,970,000Market Cap$135.05 million OptionableN/A Beta2.48 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (NASDAQ:ACOG) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.